Bicarbonate

Bicarbonate

SCHEMBL5079792

Cl.O=C([O-])O.[Na+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL5373853 0.95
Bicarbonate SCHEMBL16914495 0.95
Bicarbonate SCHEMBL222994 0.94 CA4 (0.60)
Bicarbonate SCHEMBL5403678 0.94 CA4 (0.60)
Bicarbonate SCHEMBL10646323 0.94 CA4 (0.60)
Bicarbonate SCHEMBL83 0.94
Bicarbonate SCHEMBL15321596 0.94 CA4 (0.60)
Bicarbonate SCHEMBL1332486 0.94
Bicarbonate SCHEMBL1332636 0.94
Bicarbonate SCHEMBL1929377 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116751173-A Green synthesis method of drug intermediate 易简和成(江苏)医药科技有限公司 2023-09-15 CN claimed
CN-113838315-B Portable multimedia teaching show appearance of intelligence 广州市腾龙信息科技有限公司 2023-08-11 CN claimed
CN-110123832-B Ophthalmic composition containing non-drug-resistant bactericide 东南大学 2022-06-03 CN claimed
CN-110123832-A A kind of ophthalmic composition containing no drug resistance fungicide 东南大学 2019-08-16 CN claimed
CN-122079839-A Amino thiocarbonyl compound, preparation method thereof and application thereof in preparation of medicines for preventing or treating toxoplasma infection 2026-05-26 CN disclosed
US-20250369965-A1 FORMULATION, A KIT, AND METHOD FOR FOOD ALLERGEN DETECTION LEO VERIFICATION SYSTEMS INC (US) 2025-12-04 US disclosed
US-20240408058-A1 COMPOSITIONS FOR THE EFFECTIVE TREATMENT OF VITAMIN C DEFICIENCY-RELATED DISEASES AND OTHER CONDITIONS SOMERSET THERAPEUTICS, LLC 2024-12-12 US disclosed
US-12128025-B2 Ready-to-use ascorbic acid compound compositions SOMERSET THERAPEUTICS, LLC (US) 2024-10-29 US disclosed
US-12097178-B2 Methods of efficiently treating vitamin C deficiency-related diseases and other conditions SOMERSET THERAPEUTICS, LLC (US) 2024-09-24 US disclosed
US-20240197676-A1 READY-TO-USE ASCORBIC ACID COMPOUND COMPOSITIONS SOMERSET THERAPEUTICS, LLC 2024-06-20 US disclosed
US-20240197675-A1 READY-TO-USE ASCORBIC ACID COMPOUND COMPOSITIONS SOMERSET THERAPEUTICS, LLC 2024-06-20 US disclosed
CN-116751173-A Green synthesis method of drug intermediate 易简和成(江苏)医药科技有限公司 2023-09-15 CN disclosed
CN-1337945-A Alkynyl containing hydroxamic acid compounds as TACE inhibitors AMERICAN CYANAMID CO (US) 2002-02-27 CN disclosed
CN-1024197-C Acylated derivatives of etoposide BRISTOL MYERS SQUIBB CO (US) 1994-04-13 CN disclosed
EP-0330485-B1 4-AMINO-3-ACYL QUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF GASTRIC ACID SECRETION SmithKline Beecham Intercredit B.V. (NL) 1993-05-26 EP disclosed
CN-1019969-C synthesis method of conjugated carboxylic alkenoic acid SHIONOGI & CO (JP) 1993-03-03 CN disclosed
US-5104869-A Renin inhibitors AMERICAN CYANAMID COMPANY (US) 1992-04-14 US disclosed
CN-1047869-A The acylated derivatives of etoposide BRISTOL MYERS SQUIBB CO (US) 1990-12-19 CN disclosed
US-4806549-A INHIBITOR OF GASTRIC ACID SECRETION SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-02-21 US disclosed
CN-85101417-A Method for synthesizing acrylic acid 1987-01-10 CN disclosed